Barbul Adrian, Uliyargoli Ajith
Department of Surgery, Sinai Hospital and Johns Hopkins Medical Institutions, Baltimore, MD, USA.
Crit Care Med. 2007 Sep;35(9 Suppl):S564-7. doi: 10.1097/01.CCM.0000279188.97421.FE.
Given the multiple biological, metabolic, and pharmacologic effects of supplemental arginine, much effort has been devoted to defining its role in numerous clinical conditions. Herein, we review the multiple pathways of arginine metabolism with its various enzyme systems; the effect of arginine on nutrition, healing, and immune system; and its clinical use. Sepsis has been postulated to be an arginine-deficient state and/or a syndrome with elevated levels of nitric oxide. So-called immunonutritional formulations containing various nutritional components have been used most often, yet the effects often are attributed to arginine alone. Such conclusions led to guidelines recommending against the use of arginine-supplemented diets in critically ill patients. While caution in the face of a lack of evidence for benefit in sepsis is commended, well-defined studies examining arginine monotherapy in the context of full nutritional support should be carried out so as to define the possible clinical uses of arginine in critically ill and septic patients.
鉴于补充精氨酸具有多种生物学、代谢和药理学效应,人们已付出诸多努力来明确其在众多临床病症中的作用。在此,我们综述精氨酸代谢的多种途径及其各种酶系统;精氨酸对营养、愈合和免疫系统的影响;以及其临床应用。脓毒症被推测为精氨酸缺乏状态和/或一氧化氮水平升高的综合征。含有各种营养成分的所谓免疫营养制剂最为常用,但其效果往往仅归因于精氨酸。此类结论导致指南建议重症患者不要使用补充精氨酸的饮食。尽管面对脓毒症中缺乏获益证据时保持谨慎值得称赞,但应开展在充分营养支持背景下研究精氨酸单一疗法的明确研究,以确定精氨酸在重症和脓毒症患者中的可能临床用途。